# Phase 12 Actual Model Implementation Blocker

**Status:** Actual model implementation and training blocked by missing approved requirements and dataset.

## Decision

Phase 11 explicitly selected **no final clinical algorithm**. The supplied requirements identify broad future tasks but do not select symptom analysis, disease-risk prediction, report analysis, medicine information, drug interaction detection, or educational recommendation as the first task. They also do not select Logistic Regression, Random Forest, Decision Tree, a language model, a retrieval model, or any other algorithm.

The current project contains no approved dataset, target variable, label definition, feature schema, dataset version, licensing record, clinical operating point, or evaluation protocol. The repository scan found no candidate CSV/TSV/JSONL/Parquet/ARFF/Feather dataset and no model artifact. The current Django records, prescriptions, and reports are application data, not an approved model-training dataset, and real patient data may not be used for training.

> **Required Phase 12 statement:** Actual model training was deferred because Phase 11 selected no final algorithm and the project contains no approved, licensed dataset with a documented target, feature schema, and authorization for model training.

## Work legitimately completed

The Phase 11 reusable interfaces remain the maximum justified implementation: schema validation, deterministic pass-through preprocessing, authorization context, structured response schema, deferred model adapter, service orchestration, safety validation, explainability boundary, and non-sensitive audit metadata. These components are tested with clearly labeled unit-test fixtures and do not represent clinical data or model performance.

No new algorithm file is created because doing so would falsely imply a selection. No dataset is downloaded, no medical website is scraped, no real patient record is used, and no fake training rows are manufactured.

## Required inputs before actual implementation

Before Phase 12 can train or implement a clinically meaningful model, the project owner must approve one exact task, target variable, inclusion/exclusion criteria, feature schema, missing-value policy, dataset source and license, privacy/consent handling, patient-level or temporal split, random seed, preprocessing version, evaluation metrics, clinical safety boundary, and human-review workflow.

## Scope boundary

No Django AI endpoint, model persistence, frontend integration, chatbot, RAG, LLM, external provider, database model, migration, or UI change is introduced. Phase 13 evaluation cannot begin until an approved model and dataset exist.
